Cochlear implant recipient JOHN ROSS is president of CICADA Queensland and a Soundfair ambassador. He relays his hearing loss and...
Read moreDetailsAmerica’s Food and Drug Administration (FDA) has approved Gomekli as the first drug to treat neurofibromatosis type 1 (NF1) in...
Read moreDetailsResearchers are investigating a novel molecule which they claim offers hope of an effective treatment for acute sudden hearing loss...
Read moreDetailsAmerican doctors have documented 84 hearing-related adverse events in patients taking teprotumumab (Tepezza) for thyroid eye disease, a treatment which...
Read moreDetailsThe latest NHMRC grants will fund brain stimulation treatment for tinnitus, and novel otitis media therapies including gel medication to...
Read moreDetailsOtitis media is among the most common conditions seen at Australia’s Medicare Urgent Care Clinics, according to new data released...
Read moreDetailsDeafness Forum Australia will host a virtual national summit on Friday 15 November to discuss how congenital cytomegalovirus (cCMV)) and...
Read moreDetailsThe links between hearing impairment, cognitive decline and dementia are receiving much attention as studies point to an association. Other...
Read moreDetailsAn American study has documented a high prevalence of audiometric hearing loss but limited use of hearing aids in older...
Read moreDetailsEar Science Institute Australia is developing a world-first prosthetic eardrum based on silk fibroin biomaterial using silk spun from silkworms...
Read moreDetailsHearing Practitioner Australia is the only independent business-to-business publication for the nation’s hearing industry. The multi-channel platform has been established out of the need for premium, local and independent content relevant to today’s audiologists, audiometrists, otolaryngologists/ENTs and other hearing professionals in Australia.
© 2025 All Rights Reserved. All content published on this site is the property of Prime Creative Media. Unauthorised reproduction is prohibited
© 2025 All Rights Reserved. All content published on this site is the property of Prime Creative Media. Unauthorised reproduction is prohibited